Addus HomeCare Co. (NASDAQ:ADUS) Shares Bought by Van Hulzen Asset Management LLC

Van Hulzen Asset Management LLC lifted its stake in Addus HomeCare Co. (NASDAQ:ADUSGet Rating) by 139.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,371 shares of the company’s stock after acquiring an additional 4,289 shares during the period. Van Hulzen Asset Management LLC’s holdings in Addus HomeCare were worth $689,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the company. BlackRock Inc. lifted its stake in shares of Addus HomeCare by 4.2% in the 3rd quarter. BlackRock Inc. now owns 2,560,574 shares of the company’s stock worth $204,208,000 after acquiring an additional 103,759 shares during the period. Capital World Investors raised its holdings in shares of Addus HomeCare by 11.9% during the third quarter. Capital World Investors now owns 938,900 shares of the company’s stock valued at $74,877,000 after acquiring an additional 100,000 shares during the period. Eaton Vance Management raised its holdings in shares of Addus HomeCare by 17.6% during the third quarter. Eaton Vance Management now owns 604,910 shares of the company’s stock valued at $48,219,000 after acquiring an additional 90,534 shares during the period. WCM Investment Management LLC raised its holdings in shares of Addus HomeCare by 47.8% during the fourth quarter. WCM Investment Management LLC now owns 533,252 shares of the company’s stock valued at $49,864,000 after acquiring an additional 172,426 shares during the period. Finally, Principal Financial Group Inc. increased its stake in Addus HomeCare by 2.3% in the 3rd quarter. Principal Financial Group Inc. now owns 487,485 shares of the company’s stock valued at $38,877,000 after buying an additional 10,957 shares during the period. 94.48% of the stock is owned by institutional investors.

In other Addus HomeCare news, CEO R Dirk Allison sold 1,911 shares of the company’s stock in a transaction on Friday, February 25th. The shares were sold at an average price of $70.57, for a total transaction of $134,859.27. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Brian Poff sold 692 shares of the company’s stock in a transaction on Friday, February 25th. The stock was sold at an average price of $70.58, for a total transaction of $48,841.36. The disclosure for this sale can be found here. Insiders have sold 5,196 shares of company stock worth $398,605 over the last ninety days. Insiders own 4.00% of the company’s stock.

Several equities analysts recently commented on the stock. Royal Bank of Canada upped their target price on shares of Addus HomeCare from $124.00 to $125.00 and gave the company an “outperform” rating in a research note on Thursday, March 10th. Zacks Investment Research lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Friday, March 4th. Bank of America started coverage on shares of Addus HomeCare in a research note on Wednesday, April 13th. They issued a “buy” rating and a $110.00 target price on the stock. Finally, StockNews.com began coverage on shares of Addus HomeCare in a report on Thursday, March 31st. They set a “buy” rating for the company. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $109.00.

Shares of ADUS stock traded up $3.32 during trading on Tuesday, reaching $92.50. The company’s stock had a trading volume of 202 shares, compared to its average volume of 83,074. The firm’s fifty day moving average is $81.70. The company has a current ratio of 2.76, a quick ratio of 2.76 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $1.47 billion, a P/E ratio of 32.70, a price-to-earnings-growth ratio of 2.35 and a beta of 0.84. Addus HomeCare Co. has a one year low of $68.57 and a one year high of $111.59.

Addus HomeCare (NASDAQ:ADUSGet Rating) last announced its quarterly earnings data on Thursday, February 24th. The company reported $0.86 EPS for the quarter, missing the Zacks’ consensus estimate of $0.87 by ($0.01). The business had revenue of $224.64 million during the quarter, compared to the consensus estimate of $226.22 million. Addus HomeCare had a return on equity of 8.97% and a net margin of 5.22%. The business’s revenue for the quarter was up 14.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.72 EPS. On average, equities analysts forecast that Addus HomeCare Co. will post 3.31 EPS for the current fiscal year.

Addus HomeCare Profile (Get Rating)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSGet Rating).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.